Standard pathology tests outperform molecular subtyping in bladder cancer

(Medical College of Georgia at Augusta University) While trying to develop a comparatively easy, inexpensive way to give physicians and their patients with bladder cancer a better idea of likely outcome and best treatment options, scientists found that sophisticated new subtyping techniques designed to do this provide no better information than long-standing pathology tests.